Galenica AG

Swiss Stock Exchange GALE.SW

Galenica AG EBITDA for the year ending December 31, 2023: USD 364.54 M

Galenica AG EBITDA is USD 364.54 M for the year ending December 31, 2023, a 16.06% change year over year. EBITDA means earnings before interest, taxes, depreciation, and amortization, which measures a company's operating performance by excluding non-operating expenses.
  • Galenica AG EBITDA for the year ending December 31, 2022 was USD 314.10 M, a -4.59% change year over year.
  • Galenica AG EBITDA for the year ending December 31, 2021 was USD 329.20 M, a -3.75% change year over year.
  • Galenica AG EBITDA for the year ending December 31, 2020 was USD 342.02 M, a 30.09% change year over year.
  • Galenica AG EBITDA for the year ending December 31, 2019 was USD 262.91 M, a 75.39% change year over year.
Key data
Date EBITDA Net Income EPS (Diluted) Shares (Diluted, Weighted)
Market news
Loading...
Swiss Stock Exchange: GALE.SW

Galenica AG

CEO Mr. Marc Werner
IPO Date April 7, 2017
Location Switzerland
Headquarters Untermattweg 8
Employees 7,955
Sector Health Care
Industries
Description

Galenica AG operates as a healthcare service provider in Switzerland and internationally. It operates through two segments, Products & Care, and Logistics & IT. The Products & Care segment operates 520 pharmacies, including 368 owned pharmacies and 152 partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. This segment also offers medication for treatment of patients at home; launches and distributes a portfolio of consumer health, pharmaceutical, and parapharmaceutical products; and marketing and sale services to partners in the healthcare market. The Logistics & IT segment provides range of specialized pre-wholesale services, including storage, distribution, and debt collection to pharmaceutical and healthcare companies. This segment also offers logistics and IT services, and master data system for the healthcare market; develops management solutions for the healthcare market; and publishes printed and electronic technical information on pharmaceutical products, as well as complete management solutions for pharmacies. The company was founded in 1927 and is headquartered in Bern, Switzerland.

Similar companies

SLHN.SW

Swiss Life Holding AG

USD 774.90

1.41%

HELN.SW

Helvetia Holding AG

USD 170.56

1.67%

BALN.SW

Bâloise Holding AG

USD 179.21

-0.05%

CMBN.SW

Cembra Money Bank AG

USD 95.63

2.19%

VACN.SW

VAT Group AG

USD 362.04

-0.32%

StockViz Staff

January 15, 2025

Any question? Send us an email